{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T00:11:39Z","timestamp":1788567099826,"version":"build-2803163510"},"reference-count":68,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,3,10]],"date-time":"2022-03-10T00:00:00Z","timestamp":1646870400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"abstract":"<jats:p>The leading cause of morbidity and mortality in cystic fibrosis (CF) is progressive lung disease secondary to chronic airway infection and inflammation; however, what drives CF airway infection and inflammation is not well understood. By providing a physiological snapshot of the airway, metabolomics can provide insight into these processes. Linking metabolomic data with microbiome data and phenotypic measures can reveal complex relationships between metabolites, lower airway bacterial communities, and disease outcomes. In this study, we characterize the airway metabolome in bronchoalveolar lavage fluid (BALF) samples from persons with CF (PWCF) and disease control (DC) subjects and use multi-omic network analysis to identify correlations with the airway microbiome. The Biocrates targeted liquid chromatography mass spectrometry (LC-MS) platform was used to measure 409 metabolomic features in BALF obtained during clinically indicated bronchoscopy. Total bacterial load (TBL) was measured using quantitative polymerase chain reaction (qPCR). The Qiagen EZ1 Advanced automated extraction platform was used to extract DNA, and bacterial profiling was performed using 16S sequencing. Differences in metabolomic features across disease groups were assessed univariately using Wilcoxon rank sum tests, and Random forest (RF) was used to identify features that discriminated across the groups. Features were compared to TBL and markers of inflammation, including white blood cell count (WBC) and percent neutrophils. Sparse supervised canonical correlation network analysis (SsCCNet) was used to assess multi-omic correlations. The CF metabolome was characterized by increased amino acids and decreased acylcarnitines. Amino acids and acylcarnitines were also among the features most strongly correlated with inflammation and bacterial burden. RF identified strong metabolomic predictors of CF status, including L-methionine-S-oxide. SsCCNet identified correlations between the metabolome and the microbiome, including correlations between a traditional CF pathogen, <jats:italic>Staphylococcus<\/jats:italic>, a group of nontraditional taxa, including <jats:italic>Prevotella<\/jats:italic>, and a subnetwork of specific metabolomic markers. In conclusion, our work identified metabolomic characteristics unique to the CF airway and uncovered multi-omic correlations that merit additional study.<\/jats:p>","DOI":"10.3389\/fcimb.2022.805170","type":"journal-article","created":{"date-parts":[[2022,3,10]],"date-time":"2022-03-10T11:58:53Z","timestamp":1646913533000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":18,"title":["Network Analysis to Identify Multi-Omic Correlations in the Lower Airways of Children With Cystic Fibrosis"],"prefix":"10.3389","volume":"12","author":[{"given":"John B.","family":"O\u2019Connor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madison","family":"Mottlowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica E.","family":"Kruk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Mickelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandie D.","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan Kirk","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine H.","family":"Wendt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa A.","family":"Laguna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,3,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1183\/09031936.06.00085105","article-title":"Volatile Organic Compounds in the Exhaled Breath of Young Patients With Cystic Fibrosis","volume":"27","author":"Barker","year":"2006","journal-title":"Eur. Respir. J."},{"key":"B2","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1099\/00222615-45-2-110","article-title":"The High Amino-Acid Content of Sputum From Cystic Fibrosis Patients Promotes Growth of Auxotrophic Pseudomonas Aeruginosa","volume":"45","author":"Barth","year":"1996","journal-title":"J. Med. Microbiol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J. R. Stat. Soc: Ser. B. (Methodol.)"},{"key":"B4","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.jcf.2010.09.004","article-title":"Lactate in Cystic Fibrosis Sputum","volume":"10","author":"Bensel","year":"2011","journal-title":"J. Cyst Fibros"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0124124","article-title":"Impact of the CFTR-Potentiator Ivacaftor on Airway Microbiota in Cystic Fibrosis Patients Carrying a G551D Mutation","volume":"10","author":"Bernarde","year":"2015","journal-title":"PloS One"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0002908","article-title":"Molecular Detection of Multiple Emerging Pathogens in Sputa From Cystic Fibrosis Patients","volume":"3","author":"Bittar","year":"2008","journal-title":"PloS One"},{"key":"B7","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1023\/A:1010933404324","article-title":"Random Forests","volume":"45","author":"Breiman","year":"2001","journal-title":"Mach. Learn."},{"key":"B8","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.niox.2006.06.008","article-title":"Free 3-Nitrotyrosine in Exhaled Breath Condensates of Children Fails as a Marker for Oxidative Stress in Stable Cystic Fibrosis and Asthma","volume":"15","author":"Celio","year":"2006","journal-title":"Nitric. Oxide"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1801118","DOI":"10.1183\/13993003.01118-2018","article-title":"Myeloperoxidase Oxidation of Methionine Associates With Early Cystic Fibrosis Lung Disease","volume":"52","author":"Chandler","year":"2018","journal-title":"Eur. Respir. J."},{"key":"B10","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1093\/biostatistics\/kxs038","article-title":"Structure-Constrained Sparse Canonical Correlation Analysis With an Application to Microbiome Data Analysis","volume":"14","author":"Chen","year":"2013","journal-title":"Biostatistics"},{"key":"B11","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/1465-9921-4-8","article-title":"State of the Art: Why do the Lungs of Patients With Cystic Fibrosis Become Infected and Why Can\u2019t They Clear the Infection","volume":"4","author":"Chmiel","year":"2003","journal-title":"Respir. Res."},{"key":"B12","first-page":"57","article-title":"Inflammation in the Cystic Fibrosis Lung","volume-title":"Cystic Fibrosis","author":"ChmiEL","year":"2010"},{"key":"B13","doi-asserted-by":"publisher","first-page":"2062","DOI":"10.1128\/JCM.40.6.2062-2069.2002","article-title":"Characterization of Unusual Bacteria Isolated From Respiratory Secretions of Cystic Fibrosis Patients and Description of Inquilinus Limosus Gen. Nov., Sp. Nov","volume":"40","author":"Coenye","year":"2002","journal-title":"J. Clin. Microbiol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"e26974","DOI":"10.1371\/journal.pone.0026974","article-title":"Methionine Sulfoxide Reductases are Essential for Virulence of Salmonella Typhimurium","volume":"6","author":"Denkel","year":"2011","journal-title":"PloS One"},{"key":"B15","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1378\/chest.14-1800","article-title":"Metabolomic Evaluation of Neutrophilic Airway Inflammation in Cystic Fibrosis","volume":"148","author":"Esther","year":"2015","journal-title":"Chest"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1183\/13993003.00524-2016","article-title":"Metabolomic Biomarkers Predictive of Early Structural Lung Disease in Cystic Fibrosis","volume":"48","author":"Esther","year":"2016","journal-title":"Eur. Respir. J."},{"key":"B17","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s40168-017-0234-1","article-title":"Sputum DNA Sequencing in Cystic Fibrosis: Non-Invasive Access to the Lung Microbiome and to Pathogen Details","volume":"5","author":"Feigelman","year":"2017","journal-title":"Microbiome"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1005846","article-title":"Evidence and Role for Bacterial Mucin Degradation in Cystic Fibrosis Airway Disease","volume":"12","author":"Flynn","year":"2016","journal-title":"PloS Pathog."},{"key":"B19","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1164\/rccm.200304-505SO","article-title":"Pathophysiology and Management of Pulmonary Infections in Cystic Fibrosis","volume":"168","author":"Gibson","year":"2003","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"B20","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1093\/oxfordjournals.bmb.a072585","article-title":"Microbiology of Lung Infection in Cystic Fibrosis","volume":"48","author":"Govan","year":"1992","journal-title":"Br. Med. Bull."},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2020.00174","article-title":"Longitudinal Associations of the Cystic Fibrosis Airway Microbiome and Volatile Metabolites: A Case Study","volume":"10","author":"Hahn","year":"2020","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"3805","DOI":"10.4049\/jimmunol.1201257","article-title":"Prevention of Virus-Induced Type 1 Diabetes With Antibiotic Therapy","volume":"189","author":"Hara","year":"2012","journal-title":"J. Immunol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1034\/j.1399-3003.1999.14b32.x","article-title":"Cystic Fibrosis: Inflammatory Response to Infection With Burkholderia Cepacia and Pseudomonas Aeruginosa","volume":"14","author":"Hendry","year":"1999","journal-title":"Eur. Respir. J."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1164\/rccm.201609-1954OC","article-title":"Restoring Cystic Fibrosis Transmembrane Conductance Regulator Function Reduces Airway Bacteria and Inflammation in People With Cystic Fibrosis and Chronic Lung Infections","volume":"195","author":"Hisert","year":"2017","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"B25","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.jpeds.2015.02.049","article-title":"Associations Between Gut Microbial Colonization in Early Life and Respiratory Outcomes in Cystic Fibrosis","volume":"167","author":"Hoen","year":"2015","journal-title":"J. Pediatr."},{"key":"B26","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1002\/1099-0496(200008)30:2<79::AID-PPUL1>3.0.CO;2-1","article-title":"Elevation of Nitrotyrosine and Nitrate Concentrations in Cystic Fibrosis Sputum","volume":"30","author":"Jones","year":"2000","journal-title":"Pediatr. Pulmonol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1016\/j.celrep.2019.03.086","article-title":"Direct Lung Sampling Indicates That Established Pathogens Dominate Early Infections in Children With Cystic Fibrosis","volume":"27","author":"Jorth","year":"2019","journal-title":"Cell Rep."},{"key":"B28","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1165\/rcmb.2014-0250OC","article-title":"Defective Innate Immunity and Hyperinflammation in Newborn Cystic Fibrosis Transmembrane Conductance Regulator-Knockout Ferret Lungs","volume":"52","author":"Keiser","year":"2015","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1097\/00005176-199411000-00010","article-title":"Plasma Carnitine Levels in Cystic Fibrosis","volume":"19","author":"Kovesi","year":"1994","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0167649","article-title":"Airway Microbiota in Bronchoalveolar Lavage Fluid From Clinically Well Infants With Cystic Fibrosis","volume":"11","author":"Laguna","year":"2016","journal-title":"PloS One"},{"key":"B31","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1128\/JCM.02204-13","article-title":"Clinical Insights From Metagenomic Analysis of Sputum Samples From Patients With Cystic Fibrosis","volume":"52","author":"Lim","year":"2014","journal-title":"J. Clin. Microbiol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"2006","DOI":"10.1128\/JCM.01218-15","article-title":"Assessing Airway Microbiota in Cystic Fibrosis: What More Should Be Done","volume":"53","author":"LiPuma","year":"2015","journal-title":"J. Clin. Microbiol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1126\/science.1233521","article-title":"Sex Differences in the Gut Microbiome Drive Hormone-Dependent Regulation of Autoimmunity","volume":"339","author":"Markle","year":"2013","journal-title":"Science"},{"key":"B34","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1007\/s11306-020-01760-5","article-title":"Distinctive Metabolic Profiles Between Cystic Fibrosis Mutational Subclasses and Lung Function","volume":"17","author":"Masood","year":"2021","journal-title":"Metabolomics"},{"key":"B35","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1002\/rcm.6683","article-title":"Ion Mobility and Liquid Chromatography\/Mass Spectrometry Strategies for Exhaled Breath Condensate Glucose Quantitation in Cystic Fibrosis Studies","volume":"27","author":"Monge","year":"2013","journal-title":"Rapid Commun. Mass Spectrom."},{"key":"B36","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1136\/thoraxjnl-2011-200072","article-title":"NMR Spectroscopy Metabolomic Profiling of Exhaled Breath Condensate in Patients With Stable and Unstable Cystic Fibrosis","volume":"67","author":"Montuschi","year":"2012","journal-title":"Thorax"},{"key":"B37","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1099\/00221287-148-1-257","article-title":"Determination of Bacterial Load by Real-Time PCR Using a Broad-Range (Universal) Probe and Primers Set","volume":"148","author":"Nadkarni","year":"2002","journal-title":"Microbiology"},{"key":"B38","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1002\/ppul.21078","article-title":"Exhaled Breath Condensate pH and Ammonia in Cystic Fibrosis and Response to Treatment of Acute Pulmonary Exacerbations","volume":"44","author":"Newport","year":"2009","journal-title":"Pediatr. Pulmonol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1007\/s12016-007-8039-9","article-title":"Chronic Inflammation in the Cystic Fibrosis Lung: Alterations in Inter- and Intracellular Signaling","volume":"34","author":"Nichols","year":"2008","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0257838","article-title":"Divergence of Bacterial Communities in the Lower Airways of CF Patients in Early Childhood","volume":"16","author":"O\u2019Connor","year":"2021","journal-title":"PloS One"},{"key":"B41","doi-asserted-by":"publisher","first-page":"8079","DOI":"10.1128\/JB.01138-07","article-title":"Nutritional Cues Control Pseudomonas Aeruginosa Multicellular Behavior in Cystic Fibrosis Sputum","volume":"189","author":"Palmer","year":"2007","journal-title":"J. Bacteriol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1021\/tx0155451","article-title":"Absolute Rate Constants for the Reaction of Hypochlorous Acid With Protein Side Chains and Peptide Bonds","volume":"14","author":"Pattison","year":"2001","journal-title":"Chem. Res. Toxicol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1164\/rccm.201509-1759OC","article-title":"Development of the Nasopharyngeal Microbiota in Infants With Cystic Fibrosis","volume":"193","author":"Prevaes","year":"2016","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"B44","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1093\/bioinformatics\/bts252","article-title":"SINA: Accurate High-Throughput Multiple Sequence Alignment of Ribosomal RNA Genes","volume":"28","author":"Pruesse","year":"2012","journal-title":"Bioinformatics"},{"key":"B45","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s40168-019-0636-3","article-title":"Neutrophilic Proteolysis in the Cystic Fibrosis Lung Correlates With a Pathogenic Microbiome","volume":"7","author":"Quinn","year":"2019","journal-title":"Microbiome"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1038\/ismej.2015.207","article-title":"Microbial, Host and Xenobiotic Diversity in the Cystic Fibrosis Sputum Metabolome","volume":"10","author":"Quinn","year":"2016","journal-title":"ISME J."},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1128\/mSystems.00292-20","article-title":"High-Resolution Longitudinal Dynamics of the Cystic Fibrosis Sputum Microbiome and Metabolome Through Antibiotic Therapy","volume":"5","author":"Raghuvanshi","year":"2020","journal-title":"mSystems"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00319","article-title":"Amino Acids As Mediators of Metabolic Cross Talk Between Host and Pathogen","volume":"9","author":"Ren","year":"2018","journal-title":"Front. Immunol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1203\/PDR.0b013e3181df4ea0","article-title":"Metabolomics of Volatile Organic Compounds in Cystic Fibrosis Patients and Controls","volume":"68","author":"Robroeks","year":"2010","journal-title":"Pediatr. Res."},{"key":"B50","doi-asserted-by":"publisher","first-page":"5176","DOI":"10.1128\/JCM.42.11.5176-5183.2004","article-title":"Characterization of Bacterial Community Diversity in Cystic Fibrosis Lung Infections by Use of 16s Ribosomal DNA Terminal Restriction Fragment Length Polymorphism Profiling","volume":"42","author":"Rogers","year":"2004","journal-title":"J. Clin. Microbiol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1164\/rccm.201404-0703OC","article-title":"Clinical Mechanism of the Cystic Fibrosis Transmembrane Conductance Regulator Potentiator Ivacaftor in G551D-Mediated Cystic Fibrosis","volume":"190","author":"Rowe","year":"2014","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"B52","doi-asserted-by":"publisher","first-page":"1992","DOI":"10.1056\/NEJMra043184","article-title":"Cystic Fibrosis","volume":"352","author":"Rowe","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"B53","doi-asserted-by":"publisher","first-page":"E1378","DOI":"10.1152\/ajpendo.00656.2013","article-title":"Acylcarnitines Activate Proinflammatory Signaling Pathways","volume":"306","author":"Rutkowsky","year":"2014","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"B54","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1385\/CRIAI:23:1:041","article-title":"Monitoring Inflammation in CF. Cytokines","volume":"23","author":"Sagel","year":"2002","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1164\/rccm.201103-0474CI","article-title":"The Emerging Field of Quantitative Blood Metabolomics for Biomarker Discovery in Critical Illnesses","volume":"184","author":"Serkova","year":"2011","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"B56","doi-asserted-by":"publisher","first-page":"4336","DOI":"10.1093\/bioinformatics\/btz226","article-title":"Unsupervised Discovery of Phenotype-Specific Multi-Omics Networks","volume":"35","author":"Shi","year":"2019","journal-title":"Bioinformatics"},{"key":"B57","doi-asserted-by":"publisher","first-page":"53","DOI":"10.2217\/17460913.1.1.53","article-title":"Cystic Fibrosis: A Polymicrobial Infectious Disease","volume":"1","author":"Sibley","year":"2006","journal-title":"Future Microbiol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/0005-2760(82)90196-5","article-title":"Lipid Composition of Tracheobronchial Secretions From Normal Individuals and Patients With Cystic Fibrosis","volume":"710","author":"Slomiany","year":"1982","journal-title":"Biochim. Biophys. Acta"},{"key":"B59","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1097\/MOP.0000000000000212","article-title":"The Pediatric Microbiome and the Lung","volume":"27","author":"Tracy","year":"2015","journal-title":"Curr. Opin. Pediatr."},{"key":"B60","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1093\/bioinformatics\/17.6.520","article-title":"Missing Value Estimation Methods for DNA Microarrays","volume":"17","author":"Troyanskaya","year":"2001","journal-title":"Bioinformatics"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0082432","article-title":"Microbiota and Metabolite Profiling Reveal Specific Alterations in Bacterial Community Structure and Environment in the Cystic Fibrosis Airway During Exacerbation","volume":"8","author":"Twomey","year":"2013","journal-title":"PloS One"},{"key":"B62","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1038\/nrd1776","article-title":"The Emerging Field of Lipidomics","volume":"4","author":"Wenk","year":"2005","journal-title":"Nat. Rev. Drug Discov"},{"key":"B63","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1038\/ismej.2011.104","article-title":"Spatial Distribution of Microbial Communities in the Cystic Fibrosis Lung","volume":"6","author":"Willner","year":"2012","journal-title":"ISME J."},{"key":"B64","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1080\/13547500802688194","article-title":"Metabolomic Analysis of Bronchoalveolar Lavage Fluid From Cystic Fibrosis Patients","volume":"14","author":"Wolak","year":"2009","journal-title":"Biomarkers"},{"key":"B65","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.freeradbiomed.2012.05.001","article-title":"Metabolomic Profiling of Regulatory Lipid Mediators in Sputum From Adult Cystic Fibrosis Patients","volume":"53","author":"Yang","year":"2012","journal-title":"Free Radic. Biol. Med."},{"key":"B66","doi-asserted-by":"publisher","first-page":"1700832","DOI":"10.1183\/13993003.00832-2017","article-title":"Airway Microbiota Across Age and Disease Spectrum in Cystic Fibrosis","volume":"50","author":"Zemanick","year":"2017","journal-title":"Eur. Respir. J."},{"key":"B67","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1513\/AnnalsATS.201407-310OC","article-title":"Assessment of Airway Microbiota and Inflammation in Cystic Fibrosis Using Multiple Sampling Methods","volume":"12","author":"Zemanick","year":"2015","journal-title":"Ann. Am. Thorac. Soc"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0015101","article-title":"Reliability of Quantitative Real-Time PCR for Bacterial Detection in Cystic Fibrosis Airway Specimens","volume":"5","author":"Zemanick","year":"2010","journal-title":"PloS One"}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2022.805170\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,10]],"date-time":"2022-03-10T11:59:00Z","timestamp":1646913540000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2022.805170\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,10]]},"references-count":68,"alternative-id":["10.3389\/fcimb.2022.805170"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2022.805170","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,10]]},"article-number":"805170"}}